glp 1 ocular side effects GLP-1 medications and eye problem risks Focus on GLP-1 drugs &

GLP-1-based therapies and resmetirom operate through distinct and potentially complementary mechanisms: while resmetirom exerts direct hepatic effects by activating THR- to enhance mitochondrial function, reduce hepatic lipogenesis, and promote lipid oxidation specifically in hepatocytes, GLP-1 RAs and multi-agonists address the upstream metabolic drivers of MASLD including insulin resistance, obesity, and systemic inflammation

With rising GLP-1 prices and the risk of regaining weight after discontinuation, lifestyle habits and foundational health are more important than ever

This is normal and does not mean the peptide is not working

Sharma I, Ahmad P